DRIO
DarioHealth·NASDAQ
--
--(--)
--
--(--)
3.60 / 10
Netural
Analyst coverage is limited to one Strong Buy, yielding a bullish tilt but lacking depth. Fund‑flow score is 7.19 (good), though all size‑segment trends are negative despite modest inflow ratios. Sentiment is neutral, reinforcing a cautious stance.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-20
InstitutionStifel
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of DRIO?
- DRIO holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.60/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
